标题
Cerebrospinal fluid biomarkers of Alzheimer’s disease
作者
关键词
Alzheimer’s disease, biomarker, cerebrospinal fluid, β-amyloid, tau, proteomics
出版物
Neuroscience Bulletin
Volume 30, Issue 2, Pages 233-242
出版商
Springer Nature
发表日期
2014-04-14
DOI
10.1007/s12264-013-1412-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease
- (2013) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- BACE1 Levels Correlate with Phospho-Tau Levels in Human Cerebrospinal Fluid
- (2013) Soraia Barao et al. Current Alzheimer Research
- Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer’s disease
- (2013) Liang-Hao Guo et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
- (2012) Mirko Bibl et al. JOURNAL OF NEURAL TRANSMISSION
- Neurotoxicity and Memory Deficits Induced by Soluble Low-Molecular-Weight Amyloid- 1-42 Oligomers Are Revealed In Vivo by Using a Novel Animal Model
- (2012) J. Brouillette et al. JOURNAL OF NEUROSCIENCE
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
- (2012) Thorlakur Jonsson et al. NATURE
- CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease
- (2012) R. Tarawneh et al. NEUROLOGY
- Biomarkers in Alzheimer's disease drug development
- (2011) Jeffrey L. Cummings Alzheimers & Dementia
- Visinin-like protein-1: Diagnostic and prognostic biomarker in Alzheimer disease
- (2011) Rawan Tarawneh et al. ANNALS OF NEUROLOGY
- Chemokines in CSF of Alzheimer's disease patients
- (2011) Jôice Dias Corrêa et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- Combined measurement of PEDF, haptoglobin and tau in cerebrospinal fluid improves the diagnostic discrimination between alzheimer’s disease and other dementias
- (2011) Jean-Daniel Abraham et al. BIOMARKERS
- Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease
- (2011) Hong Jiang et al. Molecular Neurodegeneration
- Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease
- (2011) Richard J. Perrin et al. PLoS One
- Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis
- (2011) Rebecca Craig-Schapiro et al. PLoS One
- Peptide Fingerprinting of Alzheimer's Disease in Cerebrospinal Fluid: Identification and Prospective Evaluation of New Synaptic Biomarkers
- (2011) Holger Jahn et al. PLoS One
- Bioluminescence imaging of A deposition in bigenic mouse models of Alzheimer's disease
- (2011) J. C. Watts et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteomic technologies for the identification of disease biomarkers in serum: Advances and challenges ahead
- (2011) Sandipan Ray et al. PROTEOMICS
- Nano-HPLC–MS analysis of phospholipids in cerebrospinal fluid of Alzheimer’s disease patients—a pilot study
- (2010) M. Kosicek et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
- (2010) Rebecca Craig-Schapiro et al. BIOLOGICAL PSYCHIATRY
- Macrophage Colony-Stimulating Factor (M-CSF) in Plasma and CSF of Patients with Mild Cognitive Impairment and Alzheimers Disease
- (2010) C. Laske et al. Current Alzheimer Research
- Increased Levels of Soluble LR11 in Cerebrospinal Fluid of Patients with Alzheimer Disease
- (2010) Takeshi Ikeuchi et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects
- (2010) Liana G. Apostolova et al. NEUROBIOLOGY OF AGING
- Increased Cerebrospinal Fluid F2-Isoprostanes are Associated with Aging and Latent Alzheimer’s Disease as Identified by Biomarkers
- (2010) Thomas J. Montine et al. NEUROMOLECULAR MEDICINE
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases
- (2009) Guo Nan Yin et al. BRAIN RESEARCH
- Amyloid- (1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease
- (2009) C. Mulder et al. CLINICAL CHEMISTRY
- CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
- (2009) Niklas Mattsson JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dkk-3 is elevated in CSF and plasma of Alzheimer’s disease patients
- (2009) Christoph Zenzmaier et al. JOURNAL OF NEUROCHEMISTRY
- Multimodal techniques for diagnosis and prognosis of Alzheimer's disease
- (2009) Richard J. Perrin et al. NATURE
- S100A7, a Novel Alzheimer's Disease Biomarker with Non-Amyloidogenic α-Secretase Activity Acts via Selective Promotion of ADAM-10
- (2009) Weiping Qin et al. PLoS One
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
- (2007) Sebastiaan Engelborghs et al. NEUROBIOLOGY OF AGING
- Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment
- (2007) Miroslaw Brys et al. NEUROBIOLOGY OF AGING
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started